Table 1.
Blocking reagent | [3H]TdR incorporation ± SD (c.p.m) | U/ml |
---|---|---|
Control mAb | 28925·3 ± 4666·0 | 53·50 |
Anti-OX40L mAb | 9186·0 ± 402·3 | 0·22 |
Anti-HLA-DR mAb | 8936·0 ± 652·7 | 0·19 |
CD4+ T cells and irradiated allogeneic mature DCs (mDCs) were mixed and co-cultured in a 96-well culture plate at a ratio of 1 : 300, in triplicate. Control monoclonal antibodies (mAbs) (UPC-10), anti-OX40 ligand (anti-OX40L) mAb (ik-5), or anti-human leucocyte antigen (HLA)-DR mAb (G46-6) were added to the culture at a final concentration of 100 µg/ml. After 72 hr, cell-free supernatants were collected. Background proliferation for the CTLL-2 cells was 156·0 ± 28·3 [mean counts per minute (c.p.m.) ± standard deviation (SD)].